| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |